Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation is a viable treatment for some types of female hair loss, with careful donor assessment and attention to psychological factors.

Male hair loss is mainly due to thinner hair, not less hair.

High uric acid levels link to male pattern baldness, especially in young men.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Using oral minoxidil and dutasteride together can quickly increase hair growth and volume with minimal side effects.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Genetic testing is crucial for diagnosing rare hair loss disorders.

Androgenetic alopecia is less common in Chilean Mapuche than Caucasians, but more common than Asians, with racial differences in prevalence and types.

UV light does not significantly affect minoxidil's ability to treat male pattern baldness.

Finasteride and dutasteride effectively stop or reverse hair loss in women with androgenetic alopecia, with dutasteride being more effective for women under 50.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Hair loss may indicate higher heart risk and metabolic issues.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Dutasteride is more effective than finasteride at increasing hair count and reversing hair thinning in men with hair loss, but both have similar side effects.

Scarring hair loss found in female pattern; biopsy needed for diagnosis.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Some men don't respond to common hair loss treatments, but a new inhibitor, FOL-005, shows promise for targeting unwanted hair growth.

Androgens can both increase body hair and cause scalp hair loss.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Targeting specific genes in certain pathways may help treat male pattern baldness.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Hair loss linked to heart disease in young men.

A man's baldness improved possibly due to a medication that blocks male hormones.

Stopping minoxidil treatment resumes balding; continuous use needed for results.

Minoxidil helps 32% of patients with hereditary baldness regrow hair.

Hair loss linked to higher heart disease risk in both men and women.